Rare germline mutations in<i>PALB2</i>and breast cancer risk: A population-based study
Marc Tischkowitz(University of Cambridge), Colin B. Begg(Memorial Sloan Kettering Cancer Center), William D. Foulkes(McGill University Health Centre), Nelly Sabbaghian(Jewish General Hospital), Marinela Capanu(Memorial Sloan Kettering Cancer Center), Leslie Bernstein(National Cancer Institute), Maxime Vallée(Hospices Civils de Lyon), Sean V. Tavtigian(University of Utah), Patrick Concannon(University of Florida), Jonine L. Bernstein(Memorial Sloan Kettering Cancer Center), Lili Li(Shanghai Medical College of Fudan University), Xiaolin Liang(Northwest Minzu University)
Cited by 86
Related Papers
A Draft Sequence of the Rice Genome ( <i>Oryza sativa</i> L. ssp. <i>japonica</i> )
|Science|2002|2.9k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Racial Differences in the Treatment of Early-Stage Lung Cancer
|New England Journal of Medicine|1999|1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946